Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zai Lab Ltd ADR (NQ: ZLAB )

30.99 +0.53 (+1.74%)
Streaming Delayed Price Updated: 11:13 AM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Ltd ADR

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022
-- Company to Host Conference Call and Webcast on November 10, 2022, at 8:00 a.m. ET 
From Zai Lab Limited
Via GlobeNewswire
Zai Lab Launches its first Trust Report
Outlines Company’s ESG Strategy through its Trust for Life Commitments 
From Zai Lab Limited
Via GlobeNewswire
Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket
Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private... 
Via Benzinga
Argenx's Drug Scores European Approval For Muscular Fatigue Disorder
Via Benzinga
Zai Lab: Q2 Earnings Insights
  Zai Lab (NASDAQ:ZLAB) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing... 
Via FinancialNewsMedia
Week In Review: YishengBio To List On NASDAQ Via SPAC Merger At An $834 Million Value
Beijing YishengBio will merge with a SPAC vehicle, Summit Healthcare Acquisition, to list on the NASDAQ Exchange at a pre-money equity value of $834 million. The merger is expected to provide up to... 
Via Talk Markets
Seagen, Zai Lab Ink Regional Strategic Licensing Agreement For Cervical Cancer Treatment
Via Benzinga
Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv)
From Seagen Inc.
Via Business Wire
KB Home, Darden Restaurants And Other Big Losers From Thursday
U.S. stocks closed lower with the Dow Jones dropping more than 100 points on Thursday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Kroger, DocuSign And Other Big Gainers From Friday
U.S. stocks closed higher with the Nasdaq Composite surging 250 points on Friday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash. 
Via Benzinga
US Stocks Open Higher, Dow Surges 300 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. 
Via Benzinga
Everest Medicines Descends To New Depths On String Of Bad News
Key Takeaways: The CEO of Everest Medicines resigned two days after the company announced its loss grew sharply in the first half of the year The company also lost an important potential new revenue... 
Via Benzinga
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in... 
Via Benzinga
Snap, Meta Platforms, Pinterest And Some Other Big Stocks Moving Higher On Wednesday
  Barnes & Noble Education, Inc. (NYSE: BNED) gained 16.8% to $2.64 after reporting upbeat quarterly sales. Bausch Health Companies Inc. (NYSE: BHC) gained 15.5% to $5.91. 
Via Benzinga
AbbVie Calls Off Early-Stage Trial For I-Mab's CD47-Targeted Blood Cancer Candidate
Via Benzinga
Tesla, Twitter And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
The Trade Desk, Inc. (NASDAQ: TTD) rose 17.3% to $63.90 in pre-market trading after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates. 
Via Benzinga
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. 
Via Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Karuna Therapeutics Shares Surge After Encouraging Data From Schizophrenia Candidate
Karuna Therapeutics Inc (NASDAQ: KRTX) has  
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Kingsoft Cloud Joins Chinese Companies Pivoting To Hong Kong as Delisting Risk Grows
Key Takeaway: Kingsoft Cloud has joined more than 100 companies that can be delisted in the U.S. amid an impasse in talks between Washington and Beijing over a U.S. law that requires Chinese companies... 
Via Benzinga
Week In Review: Henlius Signs $196 Million Deal For Two Oncology Bifunctional Sialidase Candidates
Shanghai Henlius Biotech acquired Greater China rights to two early-stage bifunctional sialidase candidates from Palleon Pharma, a Waltham, MA biopharma, in a deal with $196.5 million in development... 
Via Talk Markets
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.